IonQ, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that IonQ, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.24B | Mar 30, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $130.02M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $43.07M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $22.04M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $11.13M | Feb 26, 2025 |
| FY2022 | Dec 31, 2021 | $2.10M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 28, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($510.38M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($331.65M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($157.77M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($48.51M) | Feb 26, 2025 |
| FY2022 | Dec 31, 2021 | ($106.19M) | Mar 30, 2023 |
| FY2020 | Dec 31, 2020 | ($16.21M) | Jun 4, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($633.72M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($232.46M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($157.75M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($85.75M) | Feb 26, 2025 |
| FY2022 | Dec 31, 2021 | ($38.69M) | Mar 30, 2023 |
| FY2020 | Dec 31, 2020 | ($659.8K) | Jun 4, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $305.71M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $136.83M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $92.32M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $43.98M | Feb 26, 2025 |
| FY2022 | Dec 31, 2021 | $20.23M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $10.16M | Mar 28, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($283.19M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($105.68M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($78.81M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($44.70M) | Feb 26, 2025 |
| FY2022 | Dec 31, 2021 | ($26.54M) | Mar 30, 2023 |
| FY2020 | Dec 31, 2020 | ($344.8K) | Jun 4, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.42M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $17.99M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $13.70M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $9.34M | Feb 26, 2025 |
| FY2022 | Dec 31, 2021 | $7.78M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $10.03M | Mar 28, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.57B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $508.39M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $553.58M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $597.99M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $642.03M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $60.48M | Mar 28, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.76B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $124.53M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $68.59M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $29.78M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $50.80M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $6.78M | Mar 28, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.80B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $383.86M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $484.99M | Feb 26, 2025 |
| FY2024 | Dec 31, 2022 | $568.21M | Feb 26, 2025 |
| FY2024 | Dec 31, 2021 | $591.23M | Feb 26, 2025 |
| FY2022 | Dec 31, 2020 | $53.70M | Mar 30, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.96B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $9.90M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $742.0K | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $742.0K | Feb 26, 2025 |
| FY2022 | Dec 31, 2021 | $0 | Mar 30, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.19B) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($683.72M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($352.07M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | ($194.30M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | ($145.79M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($39.61M) | Mar 28, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $54.39M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $35.67M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $44.37M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $399.03M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $36.12M | Mar 28, 2022 |
| FY2021 | Dec 31, 2019 | $59.53M | Mar 28, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 362.59M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 221.92M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 206.61M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 199.86M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 195.63M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 118.15M | Mar 28, 2022 |